Intravitreal steroids for macular edema in diabetes

Cochrane Database of Systematic Reviews

Volumn , Issue 1, 2008, Pages

  Grover, Donald ^a   Li, T J ^b   Chong, C C W ^b  

^a STRONG MEMORIAL HOSPITAL   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

CORTICOSTEROID DERIVATIVE; DEXAMETHASONE; FLUOCINOLONE ACETONIDE; STEROID; TRIAMCINOLONE ACETATE;

BLEEDING; BLINDNESS; CATARACT; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; DIABETIC MACULAR EDEMA; DRUG DELIVERY SYSTEM; DRUG EFFECT; DRUG EFFICACY; DRUG SAFETY; ENDOPHTHALMITIS; FOLLOW UP; HUMAN; HYPOPYON; INFLAMMATION; INTRAOCULAR HYPERTENSION; LASER COAGULATION; OUTCOME ASSESSMENT; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL; RETINA DETACHMENT; REVIEW; RISK FACTOR; SIDE EFFECT; SURGICAL TECHNIQUE; VISUAL ACUITY; VISUAL IMPAIRMENT;

EID: 44949213923     PISSN: 1469493X     EISSN: None     Source Type: Journal    
DOI: 10.1002/14651858.CD005656.pub2     Document Type: Review

References (41)

1. Audren 2006 {published and unpublished data} Audren F, Erginay A, Haouchine B, Benosman R, Conrath J, Bergmann JF, et al.Intravitreal triamcinolone acetonide for diffuse diabetic macular oedema: 6-month results of a prospective controlled trial. Acta ophthalmologica Scandinavica 2006;84(5):624-30.
2. Massin P, Audren F, Haouchine B, Erginay A, Bergmann JF, Benosman R, et al.Intravitreal triamcinolone acetonide for diabetic diffuse macular edema: preliminary results of a prospective controlled trial. Ophthalmology 2004;111(2):218-24.
3. Avitabile 2005 {published data only} *Avitabile T, Longo A, Reibaldi A. Intravitreal triamcinolone compared with macular laser grid photocoagulation for the treatment of cystoid macular edema. American Journal of Ophthalmology 2005; 140(4):695-702.
4. Jonas 2006 {published data only} *Jonas JB, Kampperter BA, Harder B, Vossmerbaeumer U, Sauder G, Spandau UH. Intravitreal triamcinolone acetonide for diabetic macular edema: a prospective, randomized study. Journal of Ocular Pharmacology & Therapeutics 2006;22(3):200-7.
5. Kuppermann 2007 {unpublished data only} Kuppermann BD, Blumenkranz MS, Haller JA, Williams GA, Posurdex Study Group. An Intravitreous Dexamethasone Bioerodible Drug Delivery System for the Treatment of Persistent Diabetic Macular Edema. Association for Research in Vision and Ophthalmology Annual Meeting. 2003.
6. Kuppermann BD, Blumenkranz MS, Haller JA, Williams GA, Weinberg DV, Chou C, et al.Randomized Controlled Study of an Intravitreous Dexamethasone Drug Delivery System in Patients With Persistent Macular Edema. Archives of Ophthalmology 2007;125(3): 309-17.
7. Pearson 2002 {unpublished data only} Nancy Groves, Reviewed by Pearson P A. Steroids implant reduces retinal thickness, improves vision. Ophthalmology Times November 15, 2004:24-6.
8. Pearson PA, Baker CW, Eliott D, Ip MS, Morese LS, Callanan DG. Fluocinolone Acetonide Intravitreal Implant for Diabetic Macular Edema: 2 Year Results. Association for Research in Vision and Ophthalmology Annual Meeting. 2004.
9. Pearson PA, Baker CW, Eliott D, Ip MS, Morese LS, Callanan DG. Fluocinolone Acetonide Intravitreal Implant in Patients with Diabetic Macular Edema. American Academy of Ophthalmology Annual Meeting. 2002.
10. Pearson PA, Eliott D, Baker CW, Ip MS, Morese LS, Callanan DG. Fluocinolone Acetonide Intravitreal Implant in Patients with Diabetic Macular Edema. Association for Research in Vision and Ophthalmology Annual Meeting. 2003.
11. Pearson 2005 {unpublished data only} Nancy Groves, Reviewed by Pearson P A. Patients with DME have response to fluocinolone acetonide intravitreal implant in study outcomes. Ophthalmology Times August 1, 2006:38.
12. Pearson PA, Bevy B, Fluconolone Acetonide Implant Study Group. Fluocinolone Acetonide Intravitreal Implant to Treat Diabetic Macular Edema: 2-year Results of a Multi-Center Clinical Trial. Association for Research in Vision and Ophthalmology Annual Meeting. 2005.
13. Pearson PA, Levy B, Comstock T, Fluocinolone Acetonide Implant Study Group. Fluocinolone Acetonide Intravitreal Implant to Treat Diabetic Macular Edema: 3-Year Results of a Multi-Center Clinical Trial. Association for Research in Vision and Ophthalmology Annual Meeting. 2006.
14. Sutter 2004 {published and unpublished data} Gillies MC, Sutter FK, Simpson JM, Larsson J, Ali H, Zhu M. Intravitreal Triamcinolone for Refractory Diabetic Macular Edema Two-Year Results of a Double-Masked, Placebo-Controlled, Randomized Clinical Trial. Ophthalmology 2006;113(9):1533-8.
15. *Sutter FK, Simpson JM, Gillies MC. Intravitreal triamcinolone for diabetic macular edema that persists after laser treatment: three-month efficacy and safety results of a prospective, randomized, double-masked, placebo-controlled clinical trial. Ophthalmology 2004; 111(11):2044-9.
16. Bandello 2004 Bandello F, Polito A, Dimastrogiovanni A, Palsslos I. Intravitreal triamcinolone associated with grid laser photocoagulation for diffuse diabetic macular edema. Macular Society Annual Meeting. 2004.
17. Bonini-Filho 2005 Bonini-Filho MA, Jorge R, Barbosa JC, Calucci D, Cardillo JA, Costa RA. Intravitreal injection versus sub-Tenon's infusion of triamcinolone acetonide for refractory diabetic macular edema: a randomized clinical tiral. Investigative Ophthalmology & Visual Science 2005;46(10):3845-9.
18. Cardillo 2005 Cardillo JA, Melo LA Jr, Costa RA, et al.Comparison of intravitreal versus posterior sub-Tenon's capsule injection of triamcinolone acetonide for diffuse diabetic macular edema. Ophthalmology 2005;112 (9):1157-63.
19. Er 2005 Er H, Yilmaz H. Intravitreal cortisone injection for refractory diffuse diabetic macular edema. Ophthalmologica 2005;219(6):394-400.
20. Jonas 2004 Jonas JB, Harder B, Kamppeter BA. Inter-eye difference in diabetic macular edema after unilateral intravitreal injection of triamcinolone acetonide. American Journal of Ophthalmology 2004;138(6):970-7.
21. Spandau 2005 Spandau UH, Derse M, Schmitz-Valckenberg P, Papoulis C, Jonas JB. Dosage dependency of intravitreal triamcinolone acetonide as treatment for diabetic macular oedema. British Journal of Ophthalmology 2005;89(8):999-1003.
22. Verma 2004 Verma LK, Vivek MB, Kumar A, Tewari HK, Venkatesh P. A prospective controlled trial to evaluate the adjunctive role of posterior subtenon triamcinolone in the treatment of diffuse diabetic macular edema. Journal of Ocular Pharmacology & Therapeutics 2004;20(4): 277-84.
23. Ip 2004 A randomized trial comparing intravitreal triamcinolone acetonide and laser photocoagulation for DME.. Ongoing study June 2004.
24. Aroca 2004 Aroca PR, Salvat M, Fernandez J, Mendez I. Risk factors for diffuse and focal macular edema. Journal of Diabetes Complications 2004;18 (4):211-5.
25. CDCP 1996 Centers for Disease Control and Prevention. Blindness caused by diabetes: Massachusetts, 1987-1994. Morbidity and Mortality Weekly Report 1996;45(43):937-41.
26. Ciulla 2004 Ciulla TA, Walker JD, Fong DS, Criswell MH. Corticosteroids in posterior segment disease: an update on new delivery systems and new indications. Current Opinions in Ophthalmology 2004;15(3):211-20.
27. Cunha-Vaz 1998 Cunha-Vaz J. Diabetic macular edema. European Journal of Ophthalmology 1998;8:127-30.
28. DCCT 1993 The Diabetes Control and Complications Trial (DCCT) Research Group. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. New England Journal of Medicine 1993;329: 977-86.
29. Deeks 2006 Deeks JJ, Higgins JPT, Altman DG, editors. Analysing and presenting data. Cochrane Handbook for Systematic Reviews of Interventions 4.2.6 [updated September 2006]; Section 8. In: The Cochrane Library, Issue 4, 2006. Chichester, UK: John Wiley & Sons, Ltd.
30. DRS 1978 Diabetic Retinopathy Study Research Group. Photocoagulation treatment of proliferative diabetic retinopathy: the second report of DRS findings. Ophthalmology 1978;85:82-106.
31. ETDRS 1985 Early Treatment Diabetic Retinopathy Study Research Group. Photocoagulation for diabetic macular edema. Early Treatment Diabetic Retinopathy Study report number 1. Archives ofOphthalmology 1985; 103(12):1796-806.
32. Glanville 2006 Glanville JM, Lefebvre C, Miles JN, Camosso-Stefinovic J. How to identify randomized controlled trials in MEDLINE: ten years on. Journal of the Medical Library Association 2006;94(2):130-6.
33. Higgins 2006 Higgins JPT, Green S, editors. Assessment of study quality. Cochrane Handbook for Systematic Reviews of Interventions 4.2.6 [updated September 2006]; Section 6. In: The Cochrane Library, Issue 4, 2006. Chichester, UK: John Wiley & Sons, Ltd.
34. Jonas 2003 Jonas JB, Kreissig I, Sofker A, Degenring RF. Intravitreal injection of triamcinolone for diffuse DME. Archives of Ophthalmology 2003; 121:57-61.
35. Karacorlu 2004 Karacorlu M, Ozdemir H, Karacorlu S, Alacali N, Mudun B, Burumcek E. Intravitreal triamcinolone as a primary therapy in diabetic macular oedema. Eye 2005;19(4):382-6.
36. Klein 1984 Klein R, Klein BE, Moss SE, Davis MD, DeMets DL. The Wisconsin epidemiologic study of diabetic retinopathy. IV. Diabetic macular edema. Ophthalmology 1984;91(12):1464-74.
37. Massin 2004 Massin P, Audren F, Haouchine B, Erginay A, Bergmann JF, Benosman R, et al.Intravitreal triamcinolone acetonide for diabetic diffuse macular edema: preliminary results of a prospective controlled trial. Ophthalmology 2004;111(2):218-24.
38. Tranos 2004 Tranos PG, Wickremasinghe SS, Stangos NT, Topouzis F, Tsinopoulos I, Pavesio CE. Macular edema. Survey of Ophthalmology 2004;49 (5):470-90.
39. UKPDS 1998 UKPDS Group. Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). Lancet 1998; 352(1998):837-53.
40. Verma 2004 Verma LK, Vivek MB, Kumar A, Tewari HK, Venkatesh P. A prospective controlled trial to evaluate the adjunctive role of posterior subtenon triamcinolone in the treatment of diffuse DME. Journal of Ocular Pharmacology and Therapeutics 2004;20(4):277-84.
41. Williams 2004 Williams R, Airey M, Baxter H, Forrester J, Kennedy-Martin T, Girach A. Epidemiology of diabetic retinopathy and macular oedema: a systematic review. Eye 2004;18(10):963-83.